Influenza B in Transplant Patients

Johan Aschan Department of Transplantation Surgery, Clinical Immunology and Medicine, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden; Department of Infectious Diseases, Danderyd Hospital, Stockholm, Sweden; Virus Department, Central Microbiological Laboratory, Stockholm, Sweden

Olle Ringdén Department of Transplantation Surgery, Clinical Immunology and Medicine, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden; Department of Infectious Diseases, Danderyd Hospital, Stockholm, Sweden; Virus Department, Central Microbiological Laboratory, Stockholm, Sweden

Per Ljungman Department of Transplantation Surgery, Clinical Immunology and Medicine, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden; Department of Infectious Diseases, Danderyd Hospital, Stockholm, Sweden; Virus Department, Central Microbiological Laboratory, Stockholm, Sweden

Jan Andersson Department of Transplantation Surgery, Clinical Immunology and Medicine, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden; Department of Infectious Diseases, Danderyd Hospital, Stockholm, Sweden; Virus Department, Central Microbiological Laboratory, Stockholm, Sweden

Ilona Lewensohn-Fuchs Department of Transplantation Surgery, Clinical Immunology and Medicine, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden; Department of Infectious Diseases, Danderyd Hospital, Stockholm, Sweden; Virus Department, Central Microbiological Laboratory, Stockholm, Sweden

Marianne Forsgren Department of Transplantation Surgery, Clinical Immunology and Medicine, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden; Department of Infectious Diseases, Danderyd Hospital, Stockholm, Sweden; Virus Department, Central Microbiological Laboratory, Stockholm, Sweden

References

Meyers J D, Flournoy N, Thomas E D. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478–488
PubMed Web of Science ®Google Scholar
Hermodsson S. Ortomyxovirus. Medicinsk virologi, E Lycke, E Norrby. AWE/Gebers, Stockholm 1981; 317–327, (In Swedish.)
Google Scholar
Fernandez H, Banks G, Smith R. Ribavirin: a clinical overview. Eur J Epidemiol 1986; 2: 1–14
PubMedGoogle Scholar
Ringdén O, Bäckman L, Lönnqvist B, Heimdahl A, Lindholm A, Bolme P, Gahrton G. A randomized trial comparing the use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematologic malignancies. Bone Marrow Transplant 1986; 1: 41–51
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Influenza B in Transplant Patients

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Influenza B in Transplant Patients

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date